ClinicalTrials.gg
Status unknownNCT05308771Updated Apr 4, 2022

To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery

An interventional study of VPC syringe in Abdominal Hernia, Abdominal Wall Defect and Abdominal Neoplasm, sponsored by Centre Hospitalier Universitaire de Tivoli. Status unknown at 1 site in Belgium. Open to participants aged Up to 16 Years. Per ClinicalTrials.gov, last updated 2022-04-04.

Sponsored by Centre Hospitalier Universitaire de Tivoli · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
Up to 16 Years
Sex
All
01

Study summary

Pediatric epidural anesthesia has emerged as a safe and effective regional anesthesia technique for providing intraoperative and postoperative analgesia in thoracic and abdominal surgery. The loss of resistance technique is the gold standard for the placement of the epidural.

The VPC (visual pressure control) syringes developed by PAJUNK enable direct visualization of the introduction of the needle into the epidural space.

Read the detailed description

This trial is a non blinded, pilot study. A minimum of 15 children between the ages of 0 and 16 who require surgery that may benefit from epidural anesthesia will be enrolled.

The number of attempts, the complications (dural and vascular punctures, neurological complications) and the degree of satisfaction of the operator measured by a 7-point likert scale will be studied as secondary objectives.

02

Conditions studied

  • Abdominal Hernia
  • Abdominal Wall Defect
  • Abdominal Neoplasm
  • Urogenital Disease
  • Urologic Neoplasms
  • Thoracic Diseases
  • Lung Diseases
03

In context

Hernia, Abdominal

82 studies on the registry are indexed under Hernia, Abdominal; 19 are open to participants now.

This study's planned enrollment of 15 is below the median of 90 across 48 interventional studies indexed under Hernia, Abdominal.

Browse Hernia, Abdominal studies →

Lead sponsor

Centre Hospitalier Universitaire de Tivoli is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children aged from 0 to 16y
  • surgical procedure that can benefit from a lumbar or low thoracic epidural anesthesia

Exclusion criteria

Exclusion Criteria:

  • parental refusal
  • allergy to local anesthetics
  • coagulation disorders
  • spine abnormalities
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Epidural anesthesia using VPC syringe

    Epidural anesthesia detection using VPC syringe

    Device: VPC syringe

Interventions

  • DeviceVPC syringe

    Use of the visual pressure control syringe for epidural space detection

06

What researchers measure

Primary outcomes

  1. successful detection of the epidural space

    The primary objective will be successful detection of the epidural space by visualization of dural displacement upon injection of local anesthetic with real-time ultrasound and/or absence of pain at the incision established by the absence of more than 10% elevation in heart rate.

    Time frame: 24 hours

Secondary outcomes

  1. Number of participants with vascular puncture

    puncture of a vessel with the epidural needle or catheter

    Time frame: 24 hours

  2. Number of participants with dural puncture

    dura mater breach with needle

    Time frame: 24 hours

  3. Number of participants with nerve damage

    transient of permanent nerve damage

    Time frame: Month 3

  4. Operator's satisfaction questionnaire

    study of the operator's satisfaction by a seven-point rating scale where 1 is extremely dissatisfied and 7 is extremely satisfied

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05308771
Lead sponsor
Centre Hospitalier Universitaire de Tivoli
Responsible party
Emmanuel Noel (Deputy head of anesthesiology department, Centre Hospitalier Universitaire de Tivoli) — Principal investigator
First posted
Apr 4, 2022
Start date
Mar 25, 2022
Primary completion
Sep 2022 (estimated)
Completion
Sep 2022 (estimated)
Last update
Apr 4, 2022

Study contacts

Emmanuel Noel, MD
Contact
enoel@chu-tivoli.be
+3264277480
Mickael Leclercq, MD
Contact
mleclerc@chu-tivoli.be
+3264274932
Emmanuel Noel, MD
principal investigator · Centre Hospitalier Universitaire de Tivoli

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion